Indeed gene expression profiling revealed that GLUD1 and GLUD2 that generate α-ketoglutarate via glutamate oxidation, are selectively and consistently up-regulated in glioma cells harboring IDH mutations. This evidence concerns the gene GLUD2 and central nervous system cancer.